The Safety of Vardenafil in Patients Undergoing Cardiac Surgery

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Ischemia-reperfusion Injury.
Interventions
DRUG

Vardenafil

10 mg PO once

Trial Locations (1)

23249

McGuire VAMC, Richmond

Sponsors
All Listed Sponsors
lead

McGuire Research Institute

OTHER